Clinical and Translational Radiation Oncology
Early and late CTCAE and patient-reported outcomes following breast radiotherapy in the REQUITE cohort
By Tina Bockstiegel, Adam Webb, Miguel E. Aguado-Barrera and 22 others.
Abstract
Purpose
The international REQUITE study and its follow-up studies (RADprecise/REQUITEplus) prospectively collected longitudinal data from patients undergoing radiotherapy for breast, prostate, or lung cancer. We present data from 2057 women with breast cancer, describing patient-reported outcomes and acute and late adverse effects.